pbt & prr ...re: thoughts? -time for rebound
Agreed.....note that PRR and Prana Biotechnology have a collaboration with the Austin Research Institute for the development of a vaccine for Alzheimer's Disease. The Austin Research Institute is an independent medical research institute and has affiliation agreements with the University of Melbourne and Victoria University.
PRIMA BIOMED LTD [PRR]
Last Updated 18/03/2004
CORPORATE DETAILS GICS Sector 35: Health Care GICS Industry Group 3520: Pharmaceuticals & Biotechnology Head Office Unit 7, 79-83 High St, Kew, VIC, 3101 Telephone (03) 9854 5700 Facsimile (03) 9854 5777 Website www.primabiomed.com.au
First Listed 23/06/1988 Balance Date 30 June AGM 26/09/2003
Dividend Reinvestment? None
PRINCIPAL ACTIVITY Prima Biomed Ltd (PRR) aims to identify, fund, develop and manage biotechnology research, as to produce potential products for human and animal health care.
CANCER VAC LIMITED (65%): Cancer Vac Limited is focused on immunology particularly in the areas of Cancer immunotherapy, Autoimmunity, Vaccines and Xenotransplantation. An agreement has been signed with Progen Industries to scale up manufacture of a cancer vaccine in Phase II trials.
ARTHRON LIMITED (65%): Subsidiary of Prima Biomed, Arthron is in preclinical drug development targeting rheumatoid arthritis. Development is focused on a closer source of rheumatoid arthritis, compared with existing drugs. Arthron has patents surrounding the Fc receptor and has developed a data package demonstrating that the receptor is a valid target for developing treatments for rheumatoid arthritis. The company is in discussions to co-develop the technology.
PANVAX LIMITED (65%): Panvax is involved in the development of vaccine alternatives that stimulate auto immune responses that prevent parasitic diseases and growth of tumours. The company is developing DCtag vaccine technology that has the ability to protect animals against malaria parasites and provide treatment against tumours in mice.
ONCOMAB LIMITED (65%): Oncomab is involved in the development and commercialisation of anti cancer antibodies. Oncomab antibodies recognise the tumour antigen called cripto-1 that is found in 79% of breast cancer tissues.
ALZHEIMER'S DISEASE VACCINE: PRR and Prana Biotechnology have a collaboration with the Austin Research Institute for the development of a vaccine for Alzheimer's Disease. The Austin Research Institute is an independent medical research institute and has affiliation agreements with the University of Melbourne and Victoria University.
DIRECTORS Mr Marcus Clark Mr Bryan John Frost Mr Mark Hogarth Mr Richard Revelins
PRINCIPALS Chairman Mr Bryan John Frost MD/CEO Mr Marcus Clark Company Secretary Mr Phillip Hains Mr Richard Revelins
ADVISERS Auditors Hall Chadwick
Solicitors Oakley Thompson
Bankers n/a
REGISTRY Name Security Transfers Registry Address Applecross, WA, Registry Postal Address PO Box 535, Applecross, WA, 6953 Registry Telephone (08) 9315 0933 Registry Facsimile (08) 9315 2233 Registry TollFree n/a Investor Enquiries n/a Broker Number n/a Web Site n/a
SUBSTANTIAL SHAREHOLDERS -
LATEST BALANCE Report Effect. Substantial Shareholding % Held at % Held Date Date Shareholder Eff. Date Current ------------------------------------------------------------------------------ N/A 25/11/03 Peregrine Corporate Limited 9,734,584 14.29 14.02 30/06/03 25/09/03 Bodie Investment Pty Ltd 3,819,500 6.5 5.5 30/06/03 25/09/03 Queensland Investment 3,400,000 5.79 4.9 Corporation
Note: % Held Currently refers to the percentage held calculated based on latest total number of shares outstanding.
BALANCES AS AT 2003 ANNUAL REPORT Report Effect. Substantial Shareholding % Held Date Date Shareholder Eff.Date ------------------------------------------------------------------------------ 30/06/03 25/09/03 Peregrine Corporate Limited 9,984,229 17 30/06/03 25/09/03 Bodie Investment Pty Ltd 3,819,500 6.5 30/06/03 25/09/03 Queensland Investment Corporation 3,400,000 5.79
BUYS OVER LAST 12 MONTHS Effect. Substantial Prev.% New% ShrsTraded Date Shareholder ------------------------------------------------------------------------------ There were no buys over the last 12 months.
(20min delay)